What we dispense is a compounded version, which is not FDA-approved
These prescription medications complement lifestyle changes by addressing the biological processes that control hunger, satiety, and energy storage
they are potential modulators of inflammation and autoimmune conditions, which opens up new avenues for addressing chronic conditions
Most women begin noticing appetite control, better digestion, and increased energy within 23 weeks, with visible weight loss results in 48 weeks
In clinical practice, females underweight from profound dietary restriction likewise show lower fertility with endocrine features congruent with ovarian insufficiency [46]
Does the cessation of the shortage exception apply only to injectable GLP-1 medications, or does it include oral versions as well